Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Home Clinical Trial Sponsors and OrganizationsJiangxi Qingfeng Pharmaceutical Co. Ltd.

Jiangxi Qingfeng Pharmaceutical Co. Ltd.

ACTIVE

江西省赣州市, 江西省, ChinaPrivateEstablished: 2001-12-12

Part of Qingfeng Pharmaceutical Group Co.Ltd

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

32

1 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

2001

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

11

34.4%

Not Applicable

5

15.6%

Phase 2

4

12.5%

Phase 3

4

12.5%

Phase 4

4

12.5%

Trial Status Distribution

Completed

11

34.4%

Not yet recruiting

1

3.1%

Recruiting

2

6.3%

Unknown

18

56.3%

Clinical Trials

Trials sponsored by this organization (32)

Study to Assess the Efficacy and Safety of GP681 Versus Placebo for Postexposure Prophylaxis Against Influenza

Dec 2024748 participants

Study to Evaluate the Clinical Value and Safety of Xiyanping Injection in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease(COPD) Based on Real-world Clinical Data

Not yet recruiting

Dec 20241,140 participants

Study of GP681 Tablets Compared With Placebo in Patients With Influenza at High Risk of Influenza Complications

Nov 2024328 participants

Study to Assess the Tolerability, Safety and Efficacy of GP681 Powder for Oral Suspension

Sep 202444 participants

Study to Assess Relative Bioavailability of GP681 Formulations in Healthy Chinese Male Subjects

Sep 202436 participants

GP681 in Volunteers With Hepatic Impairment Compared With Healthy Volunteers

Apr 202324 participants

A Study to Evaluate the Drug-drug Interactions (DDIs) of GP681 With Rosuvastatin, Digoxin, Itraconazole, Oseltamivir in Chinese Healthy Volunteers

Feb 202354 participants

To Assess the Efficacy of GP681 Tablet Versus Placebo in Patients With Acute Uncomplicated Influenza Virus Infection

Jul 2022591 participants

Page 1 of 4

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials32
Approvals
News

Back to Organizations